Interdisciplinary Program of Biomodulation, Myongji Universitygrid.410898.c, Yongin, Republic of Korea.
Myongji Bioefficacy Research Center, Myongji Universitygrid.410898.c, Yongin, Republic of Korea.
Microbiol Spectr. 2022 Aug 31;10(4):e0112222. doi: 10.1128/spectrum.01122-22. Epub 2022 Jul 6.
The oral cavity contains a number of microbes. They interact with each other and play an important role in human health. Among oral cariogenic microbes, Streptococcus mutans is recognized a major etiological bacteria of dental caries. Lactobacilli strains have been promoted as possible probiotic agents against S. mutans. However, their inhibitory mechanism has not been well elucidated yet. In the present study, two new compounds with strong antibiofilm activities were purified from the culture supernatant of Lactobacillus paragasseri MJM60645, which was isolated from the human oral cavity. These compounds showed strong inhibitory activities against S. mutans biofilm formation, with IC (concentration at which 50% biofilm was inhibited) of 30.4 μM for compound 1 and 18.9 μM for compound 2. However, these compounds did not show bactericidal activities against S. mutans. Structure elucidation by nuclear magnetic resonance (NMR) and mass spectrometry showed that compound 1 was composed of two arabinofuranose iminosugars jointed with one glycerol and oleic acid, and compound 2 was composed of two arabinofuranose iminosugars jointed with one glycerol and nervonic acid. To the best of our knowledge, these structures were discovered for the first time in this study. Treatment of S. mutans with compound 1 strongly downregulated expression levels of genes related to biofilm formation, including , , , , , , , and without affecting the expression of or . This study provides new insights into novel molecules produced by Lactobacillus to regulate the pathogenesis of S. mutans, facilitating a better understanding of the mechanism for interactions between Lactobacillus and S. mutans. In this study, we isolated lactic acid bacteria that inhibit streptococcal biofilm from the oral cavity of infants and identified two novel compounds from the supernatant of their culture broth. The two compounds are structurally similar, and both consist of iminosugars, glycerol, and unsaturated fatty acid. A search of the SciFinder database revealed that these structures are novel and were discovered for the first time in this study. Mechanism studies have shown that these compounds can inhibit the expression of biofilm synthesis-related genes. This is the first report that lactic acid bacteria inhibit streptococcal biofilms by small molecules with new chemical structures. This study not only expands the understanding of natural products derived from lactic acid bacteria but also provides a new paradigm for the understanding of the interaction of bacteria in the oral microbiota.
口腔中含有许多微生物。它们相互作用,在人类健康中发挥着重要作用。在口腔致龋微生物中,变形链球菌被认为是龋齿的主要病因细菌。乳杆菌菌株已被推广为抗变形链球菌的可能益生菌制剂。然而,其抑制机制尚未得到很好的阐明。本研究从分离自人体口腔的副干酪乳杆菌 MJM60645 的培养上清液中纯化得到两种具有较强抗生物膜活性的新化合物。这两种化合物对变形链球菌生物膜形成具有很强的抑制活性,化合物 1 的 IC50(抑制 50%生物膜形成的浓度)为 30.4 μM,化合物 2 的 IC50 为 18.9 μM。然而,这些化合物对变形链球菌没有杀菌活性。通过核磁共振(NMR)和质谱的结构解析表明,化合物 1 由两个阿拉伯呋喃糖亚氨基糖与一个甘油和油酸连接而成,化合物 2 由两个阿拉伯呋喃糖亚氨基糖与一个甘油和神经酸连接而成。据我们所知,这些结构在本研究中首次被发现。用化合物 1 处理变形链球菌可强烈下调与生物膜形成相关的基因表达水平,包括 、 、 、 、 、 、 和 ,而不影响 或 的表达。本研究为乳杆菌产生的调节变形链球菌发病机制的新型分子提供了新的见解,有助于更好地理解乳杆菌与变形链球菌相互作用的机制。 在这项研究中,我们从婴儿口腔中分离出抑制链球菌生物膜的乳酸杆菌,并从其培养上清液中鉴定出两种新型化合物。这两种化合物结构相似,均由亚氨基糖、甘油和不饱和脂肪酸组成。在 SciFinder 数据库中检索显示,这些结构是新颖的,是在本研究中首次发现的。机制研究表明,这些化合物可以抑制生物膜合成相关基因的表达。这是首次报道乳酸杆菌通过具有新化学结构的小分子抑制链球菌生物膜。本研究不仅扩展了对来源于乳酸杆菌的天然产物的认识,而且为理解口腔微生物群中细菌的相互作用提供了新的范例。